Meeting Report

Targeting p53 in MDS: Highlights From SOHO 2021

Alexis C. Geppner, MLS, CTTS, PA-C


J Adv Pract Oncol 2022;13(suppl 1):15–16 | https://doi.org/10.6004/jadpro.2022.13.1.12 | © 2022 Harborside™


  

ABSTRACT

Alexis Geppner 50X57Alexis C. Geppner, MLS, CTTS, PA-C, of The University of Texas MD Anderson Cancer Center, evaluates data from the session on p53 in myelodysplastic syndrome presented by David A. Sallman, MD, of H. Lee Moffitt Cancer Center and Research Institute, at the 2021 SOHO Annual Meeting. 




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2022 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.